Healthcare Industry News

The family of a longtime member of North Carolina's state school board says she has died from the injuries she suffered in a weekend assault.

U.S. District Judge Todd Campbell's ruling last week was the latest blow to Novartis Corp., which is facing lawsuits from hundreds of patients around the country over its bone-strengthening drugs Aredia and Zometa.

Blue Care Network announced Sept. 15 it planned to buy the membership of Physicians Health Plan of Mid-Michigan. Sparrow Health System owns the Lansing-based HMO, which has about 80,000 members.

Two of the world's biggest pharmaceutical companies said Tuesday they are uniting their animal health businesses in a deal to become the top dog in the veterinary industry.

Cell Therapeutics said Monday that the U.S. Food and Drug Administration completed its inspection of the facility in Italy that manufactures the company's pixantrone drug and "found the site in compliance and acceptable for continued manufacturing of the drug product." Pixantrone is under review by the FDA to treat relapsed/refractory aggressive ...

Swiss pharmaceutical company Roche Group said Monday it has suspended a late-stage trial for a new rheumatoid arthritis and lupus drug after several patients died from infections.

Women who drink a couple of glasses of red wine, beer or spirits a day are better at keeping the pounds off than women who do not drink at all, according to a study published Monday.

The Supreme Court will decide whether drug makers can be sued by parents who claim their children suffered serious health problems from vaccines.

AstraZeneca PLC said Monday that its cancer drug Recentin failed in a head to head late stage trial with Roche AG's Avastin in tests for use as an initial treatment against colon cancer.

Biotechnology company Isis Pharmaceuticals Inc. said Monday its fourth-quarter loss widened on a boost in research and development costs.

ARROW Energy has received a conditional $3.3 billion takeover offer from a company jointly owned by Royal Dutch Shell and PetroChina.

A few minutes after dropping his daughter off at a Little Chute day care Friday morning, Jeff Malloy found himself parked precariously on the side of fog-shrouded U.S. 41 fearing for his life.

Paramedics transported Kathy A. Taft, a member of the state Board of Education, to WakeMed on Saturday morning after she was found with serious injuries at a Raleigh home.

BRISBANE,A Calif. The Food and Drug Administration is reviewing a drug for treating a lung condition that affects around 200,000 people in the United States and Europe.

In the past year, Chinese acquisitions in the U.S. have ranged from a relatively obscure theater in Branson, Mo., to stakes in such famous brands as Coca-Cola and Johnson & Johnson.

A UCSD student walks past a poster on campus on Thursday that raises issues about diversity on campus.

Medical equipment maker HealthTronics Inc. reported a narrower fourth-quarter loss compared to a year earlier, when it absorbed $144 million in impairment charges.

Biotech's shares soar after unexpectedly supportive report on lung disease drug.

Drugmakers spent a combined $4.51 billion on ads for prescription medicines aimed at consumers.

Shares of drug developer InterMune Inc. surged Friday after federal health officials posted their review of the experimental drug pirfenidone, which is designed to treat a rare lung disease.